Correction of renal dysfunction under the influence of dietary management, exercises and lisinopril in patients with abdominal obesity and hypertension

The purpose of research is to assess the impact of diet therapy, physical activity and an ACE inhibitor (lisinopril) on renal dysfunction in patients with abdominal obesity and hypertension. The study involved 14 patients with abdominal obesity, 2-3 degrees in BMI, hypertension, I-II stage, 1 degree...

Full description

Saved in:
Bibliographic Details
Main Author: Rokutova М.К.
Format: Article
Language:English
Published: Dnipro State Medical University 2015-11-01
Series:Medičnì Perspektivi
Subjects:
Online Access:http://www.medpers.dsma.dp.ua/issues/2015/N4/23-29.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850088415943458816
author Rokutova М.К.
author_facet Rokutova М.К.
author_sort Rokutova М.К.
collection DOAJ
description The purpose of research is to assess the impact of diet therapy, physical activity and an ACE inhibitor (lisinopril) on renal dysfunction in patients with abdominal obesity and hypertension. The study involved 14 patients with abdominal obesity, 2-3 degrees in BMI, hypertension, I-II stage, 1 degree, and severe insulin resistance. Men were 9 (64.3%) patients, women - 5 (35.7%) persons. The average age of the patients was 37,0±1,7 years, mean BMI - 44.7 [35.5; 46.5] kg/m2. BP was between 140-158/90-98 mm Hg. Diroton (lisinopril, Richter Gedeon Ltd, Hungary) was administered 1 time per day in the morning at a dose of 10 mg. The effect of diet therapy, exercise and lisinopril on parameteres of renal function (glomerular filtration rate, urine protein, urine albumin, urine І2 microglobulin, urine albumin / creatinine ratio, І2- microglobulin / urine creatinine ratio). After 6 months of treatment there was a significant decrease in body weight (p<0.001) from 123.5 [110.0; 154.0] to 120.0 [105.0; 142.0] kg, with a BMI from 44.7 [35.5; 46.5] to 42.7 [33.9; 45.2] kg/m2 (p <0.001) and waist from 118.0 [105.0; 142.0] to 116.0 [105.0; 135.0] cm (p<0.05). Normalization of blood pressure was achieved in 71,4% (n=10) patients and a significant decrease in blood pressure - in 28,7% (n=4) persons in the 6th week of treatment. The level of GFR was significantly (p<0.01) decreased from 202.2 [156.1; 254.6] to 200.3 [148.8; 220.6] ml/min, the level of І2-mg decreased from 3.4 [1.1, 4.8] to 2.8 [1.4; 3.6] mg/24 h, the І2-mg / Cr urine ratio - from 2.3 [0.9, 4.0] to 1.9 [1.0, 2.7] mg/g, which is a positive point prognosis of obesity-associated nephropathy in these patients. GFR normalized in 2 (14.3%) patients, І2-mg and І2-mg / Сr ratio - only in 1 (7.1%) patients. GFR decreased in 10 (71.4%) patients, І2-mg and І2-mg / Cr ratio – in 12 (85.7%) patients. It is the result of complex treatment of diet, exercises and lisinopril. A significant reduction (p<0.01) of leptin from 95.6 [58.1; 141.9] to 87.0 [56.5; 132.6] ng/ml was observed in 13 (92.9%) patients. Patients in this group showed a significant decrease in lipid, carbohydrate metabolism and the level of insulin resistance. ACE inhibitors in combination with diet and exercises considering metabolic disorders are the complex treatment early manifestations of kidney damage in patients with abdominal obesity and hypertension.
format Article
id doaj-art-6b0bce72e4fa400a9845ac8fa7d54862
institution DOAJ
issn 2307-0404
2307-0404
language English
publishDate 2015-11-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-6b0bce72e4fa400a9845ac8fa7d548622025-08-20T02:43:00ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042307-04042015-11-012042329Correction of renal dysfunction under the influence of dietary management, exercises and lisinopril in patients with abdominal obesity and hypertensionRokutova М.К.0SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine» The purpose of research is to assess the impact of diet therapy, physical activity and an ACE inhibitor (lisinopril) on renal dysfunction in patients with abdominal obesity and hypertension. The study involved 14 patients with abdominal obesity, 2-3 degrees in BMI, hypertension, I-II stage, 1 degree, and severe insulin resistance. Men were 9 (64.3%) patients, women - 5 (35.7%) persons. The average age of the patients was 37,0±1,7 years, mean BMI - 44.7 [35.5; 46.5] kg/m2. BP was between 140-158/90-98 mm Hg. Diroton (lisinopril, Richter Gedeon Ltd, Hungary) was administered 1 time per day in the morning at a dose of 10 mg. The effect of diet therapy, exercise and lisinopril on parameteres of renal function (glomerular filtration rate, urine protein, urine albumin, urine І2 microglobulin, urine albumin / creatinine ratio, І2- microglobulin / urine creatinine ratio). After 6 months of treatment there was a significant decrease in body weight (p<0.001) from 123.5 [110.0; 154.0] to 120.0 [105.0; 142.0] kg, with a BMI from 44.7 [35.5; 46.5] to 42.7 [33.9; 45.2] kg/m2 (p <0.001) and waist from 118.0 [105.0; 142.0] to 116.0 [105.0; 135.0] cm (p<0.05). Normalization of blood pressure was achieved in 71,4% (n=10) patients and a significant decrease in blood pressure - in 28,7% (n=4) persons in the 6th week of treatment. The level of GFR was significantly (p<0.01) decreased from 202.2 [156.1; 254.6] to 200.3 [148.8; 220.6] ml/min, the level of І2-mg decreased from 3.4 [1.1, 4.8] to 2.8 [1.4; 3.6] mg/24 h, the І2-mg / Cr urine ratio - from 2.3 [0.9, 4.0] to 1.9 [1.0, 2.7] mg/g, which is a positive point prognosis of obesity-associated nephropathy in these patients. GFR normalized in 2 (14.3%) patients, І2-mg and І2-mg / Сr ratio - only in 1 (7.1%) patients. GFR decreased in 10 (71.4%) patients, І2-mg and І2-mg / Cr ratio – in 12 (85.7%) patients. It is the result of complex treatment of diet, exercises and lisinopril. A significant reduction (p<0.01) of leptin from 95.6 [58.1; 141.9] to 87.0 [56.5; 132.6] ng/ml was observed in 13 (92.9%) patients. Patients in this group showed a significant decrease in lipid, carbohydrate metabolism and the level of insulin resistance. ACE inhibitors in combination with diet and exercises considering metabolic disorders are the complex treatment early manifestations of kidney damage in patients with abdominal obesity and hypertension.http://www.medpers.dsma.dp.ua/issues/2015/N4/23-29.pdfrenal dysfunctioninsulin-resistanceabdominal obesitydiet-therapydosed physical loadsACE inhibitors
spellingShingle Rokutova М.К.
Correction of renal dysfunction under the influence of dietary management, exercises and lisinopril in patients with abdominal obesity and hypertension
Medičnì Perspektivi
renal dysfunction
insulin-resistance
abdominal obesity
diet-therapy
dosed physical loads
ACE inhibitors
title Correction of renal dysfunction under the influence of dietary management, exercises and lisinopril in patients with abdominal obesity and hypertension
title_full Correction of renal dysfunction under the influence of dietary management, exercises and lisinopril in patients with abdominal obesity and hypertension
title_fullStr Correction of renal dysfunction under the influence of dietary management, exercises and lisinopril in patients with abdominal obesity and hypertension
title_full_unstemmed Correction of renal dysfunction under the influence of dietary management, exercises and lisinopril in patients with abdominal obesity and hypertension
title_short Correction of renal dysfunction under the influence of dietary management, exercises and lisinopril in patients with abdominal obesity and hypertension
title_sort correction of renal dysfunction under the influence of dietary management exercises and lisinopril in patients with abdominal obesity and hypertension
topic renal dysfunction
insulin-resistance
abdominal obesity
diet-therapy
dosed physical loads
ACE inhibitors
url http://www.medpers.dsma.dp.ua/issues/2015/N4/23-29.pdf
work_keys_str_mv AT rokutovamk correctionofrenaldysfunctionundertheinfluenceofdietarymanagementexercisesandlisinoprilinpatientswithabdominalobesityandhypertension